Cadila healthcare launched an anti-obesity drug “Slimona” in India. The drug is used to treat obese patients with associated risk factors like type2 diabetes or dyslipidemia. Slimona (Rimonabant) is a selective CB1 Endocannabinoid (EC) receptor antagonist. The drug comes in a tablet form of strength 20 mg to be consumed before breakfast once a day and is priced at Rs 5.50 a tablet.       Obesity: A person is called obese when his Body Mass Index (BMI) is 30 or above. Obesity is mainly due to uncontrolled diet habits and sedentary lifestyle. In urban India, 29% men and 45% women are overweight. According to WHO statistics, 300 million people are obese all over the world and 1 billion people are overweight. Obesity is the major reason behind increase in incidence of type2 Diabetes.   Slimona is a new class of drug in the treatment of Obesity.   … [Read more...]